Redox regulation of antioxidant enzymes: Post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver

Molecular and Cellular Biochemistry

Volumn 393, Issue 1-2, 2014, Pages 111-122

  Sadi, Gökhan ^a   Bozan, Davut ^a   Yildiz, Huseyin Bekir ^a,b  

^a KARAMANOGLU MEHMETBEY UNIVERSITY   (Turkey)

^b MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Catalase; Diabetes; Glutathione peroxidase; Protein phosphorylation; Resveratrol

Indexed keywords

CATALASE; CYTOPLASM PROTEIN; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2; GLUCOSE BLOOD LEVEL; NFE2L2 PROTEIN, RAT; SIRT1 PROTEIN, RAT; STILBENE DERIVATIVE; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE EXPRESSION; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; PHOSPHORYLATION;

ANIMALS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; HUMANS; LIVER; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; SIRTUIN 1; STILBENES; SUPEROXIDE DISMUTASE;

EID: 84903478895     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2051-1     Document Type: Article

References (51)

1. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058-1070. doi:10.1161/CIRCRE SAHA.110.223545
2. Pandey KB (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2:270-278
3. Szkudelski T, Szkudelska K (2011) Anti-diabetic effects of resveratrol. Ann N Y Acad Sci 1215:34-39. doi:10.1111/j.1749-6632.2010.05844.x
4. Marques FZ, Markus MA, Morris BJ (2009) Resveratrol : cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 41:2125-2128. doi:10. 1016/j.biocel.2009.06.003
5. Szkudelska K, Szkudelski T (2010) Resveratrol, obesity and diabetes. Eur J Pharmacol 635:1-8. doi:10.1016/j.ejphar.2010.02. 054
6. Baur J, Sinclair D (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506. doi:10.1038/ nrd2060
7. Savouret JF, Quesne M (2002) Resveratrol and cancer: a review. Biomed Pharmacother 56:84-87 (Pubitemid 34241562)
8. Thirunavukkarasu M, Penumathsa SV, Koneru S et al (2007) Resveratrol alleviates cardiac dysfunction in streptozotocininduced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43:720-729. doi:10.1016/j.free radbiomed.2007.05.004
9. Groen A, Lemeer S, van der Wijk T et al (2005) Differential oxidation of protein-tyrosine phosphatases. J Biol Chem 280:10298-10304. doi:10.1074/jbc. M412424200 (Pubitemid 40395886)
10. Rhee S, Kang SW, Jeong W et al (2005) Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 17:183-189. doi:10.1016/j.ceb.2005. 02.004
11. Rhee SG (2003) Cellular regulation by hydrogen peroxide. J Am Soc Nephrol 14:211S-215S. doi:10.1097/01.ASN.0000077404. 45564.7E
12. Evans JL (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of Type 2 diabetes. Endocr Rev 23:599-622. doi:10.1210/er.2001-0039
13. Lee J-M, Johnson J a (2004) An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 37:139-143
14. Locke M, Anderson J (2011) NF-KB activation in organs from STZ-treated rats. Appl Physiol Nutr Metab 36:121-127. doi:10.1139/H10-094
15. Soufi FG, Mohammad-Nejad D, Ahmadieh H (2012) Resveratrol improves diabetic retinopathy possibly through oxidative stress- nuclear factor KB-apoptosis pathway. Pharmacol Rep 64:1505-1514
16. Morris BJ (2013) Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med 56:133-171. doi:10.1016/j.free radbiomed.2012.10.525
17. Pillai SS, Sugathan JK, Indira M (2012) Selenium downregulates RAGE and NFKB expression in diabetic rats. Biol Trace Elem Res 149:71-77. doi:10.1007/s12011-012-9401-1
18. Taguchi K, Motohashi H, Yamamoto M (2011) Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16:123-140. doi:10.1111/j.1365-2443.2010.01473.x
19. Cao C, Leng Y, Kufe D (2003) Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem 278:29667-29675. doi:10.1074/jbc.M301292200 (Pubitemid 36962352)
20. Cao C, Leng Y, Huang W et al (2003) Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases. J Biol Chem 278:39609-39614. doi:10.1074/jbc.M305770200 (Pubitemid 37248520)
21. Lowry O, Roserbrough N, Farr A, Randall R (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265-275
22. Towbin H, Staehelin T, Gordon J (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24:145-149
23. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77
24. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25:192-205
25. Jain SK, Levine SN (1995) Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocintreated diabetic rats. Free Radic Biol Med 18:337-341
26. Levine RL, Garland D, Oliver CN et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478 (Pubitemid 20279989)
27. Aebi H (1984) In methods in enzymology. Catalase Vitr. Academy Press, New York, pp 121-126
28. Paglia D, Valentine W (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
29. Baur JA (2010) Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 131:261-269. doi:10.1016/j.mad. 2010.02.007
30. Zhang J (2006) Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem J 397:519-527. doi:10.1042/ BJ20050977
31. Gadacha W, Ben-Attia M, Bonnefont-Rousselot D et al (2009) Resveratrol opposite effects on rat tissue lipoperoxidation: prooxidant during day-time and antioxidant at night. Redox Rep 14:154-158. doi:10.1179/135100009X466131
32. Upadhyay G, Singh AK, Kumar A et al (2008) Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. Eur J Pharmacol 596:146-152. doi:10.1016/j.ejphar. 2008.08.019
33. Den Hertog J, Groen A, Van Der Wijk T (2005) Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys 434:11-15. doi:10.1016/j.abb.2004.05.024 (Pubitemid 40040465)
34. Conte A, Pellegrini S, Tagliazucchi D (2003) Effect of resveratrol and catechin on PC12 tyrosine kinase activities and their synergistic protection from beta-amyloid toxicity. Drugs Exp Clin Res 29:243-255 (Pubitemid 38568631)
35. Palmieri L, Mameli M, Ronca G (1999) Effect of resveratrol and some other natural compounds on tyrosine kinase activity and on cytolysis. Drugs Exp Clin Res 25:79-85 (Pubitemid 29257598)
36. Dasgupta B, Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci USA 104:7217-7222. doi:10.1073/pnas.0610068104 (Pubitemid 47186035)
37. Hassan-Khabbar S, Cottart C-H, Wendum D et al (2008) Postischemic treatment by trans-resveratrol in rat liver ischemiareperfusion: a possible strategy in liver surgery. Liver Transpl 14:451-459. doi:10.1002/lt.21405 (Pubitemid 351524400)
38. Meyer AJ, Hell R (2005) Glutathione homeostasis and redoxregulation by sulfhydryl groups. Photosynth Res 86:435-457. doi:10.1007/s11120-005-8425-1 (Pubitemid 43042765)
39. Stevens MJ (2005) Redox-based mechanisms in diabetes. Antioxid Redox Signal 7:1483-1485. doi:10.1089/ars.2005.7.1483
40. Foyer CH, Noctor G (2005) Redox homeostasis and antioxidant signaling: a metabolic interface between stress perception and physiological responses. Plant Cell 17:1866-1875. doi:10.1105/ tpc.105.033589
41. Cao C, Leng Y, Li C, Kufe D (2003) Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response. J Biol Chem 278:12961-12967. doi:10. 1074/jbc.M300058200
42. Schmatz R, Perreira LB, Stefanello N et al (2012) Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 94:374-383. doi:10.1016/j.biochi.2011.08.005
43. Hongjun L, Colavitti R, Rovira II, Finkel T (2005) Redoxdependent transcriptional regulation. Circ Res 97:967-974. doi:10.1161/01.RES.0000188210. 72062.10
44. Arambašić J, Mihailović M, Uskoković A et al (2013) Alphalipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism. Eur J Nutr 52:1461-1473. doi:10.1007/ s00394-012-0452-z
45. Dinić S, Arambašić J, Mihailović M et al (2013) Decreased O-GlcNAcylation of the key proteins in kinase and redox signalling pathways is a novel mechanism of the beneficial effect of α-lipoic acid in diabetic liver. Br J Nutr 110(3):1-12. doi:10.1017/S0007114512005429
46. Li B, Liu S, Miao L, Cai L (2012) Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy. Exp Diabetes Res 2012:1-7. doi:10.1155/2012/216512
47. Palsamy P, Subramanian S (2011) Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 1812:719-731. doi:10.1016/j.bbadis.2011.03.008
48. Selcuk MY, Aygen B, Dogukan A et al (2012) Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-KB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats. Nutr Metab (Lond) 9:30. doi:10.1186/1743-7075-9-30
49. Kelleher AR, Fairchild TJ, Keslacy S (2010) STZ-induced skeletal muscle atrophy is associated with increased p65 content and downregulation of insulin pathway without NF-KB canonical cascade activation. Acta Diabetol 47:315-323. doi:10.1007/ s00592-010-0209-1
50. Kawahara TLA, Michishita E, Adler AS et al (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136:62-74. doi:10. 1016/j.cell.2008.10.052
51. Wu L, Zhang Y, Ma X et al (2012) The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Mol Biol Rep 39:9085-9093. doi:10.1007/s11033-012-1780-z